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Abstract 
The sodium-ion-dependent citrate carrier of Klebsiella pneumoniae (CitS) was purified by means of bioengineerical methods. By fusing the biotin 
aeceptor domain of the ct-subunit of the oxaloacetate d carboxylase of K pneumoniae to the C-terminus of CitS, purification of the carrier was 
achieved by use of a monomeric avidin-Sepharose column. Additionally, we were able to purify a CitS-protein with an N-terminal histidine-tag by 
immobilized metal chelate affinity chromatography (with NiZ+-nitrilotriacetic acid-(NTA-) resin). Both purified fusion proteins showed citrate 
transport activity after reconstitution i to liposomes by the freeze/thaw/sonication procedure. 
Key words: citS gene; Secondary active transport; Citrate carrier; Sodium ion/citrate symport; Fusion proteins, ~ty  
chromatography; Klebsiella pneumoniae 
1. Introduction 
In Klebsiella pneumoniae a unique Na+-dependent cit- 
rate carrier (CitS) is induced upon anaerobic growth on 
citrate. The properties of CitS have been investigated in 
a reconstituted proteoliposomal system with the carrier- 
protein derived from a Triton X-100 extract of K. pneu- 
moniae membranes [1] and with vesicles from citS ex- 
pressing Escherichia coli cells [2]. The DNA sequence of 
citS has recently been determined [2]; it encodes a highly 
hydrophobic protein of 446 amino acids with a predicted 
Mr of 47,531 and 12 putative membrane spanning 
~t-helices. For more detailed analyses of the citrate car- 
tier, we decided to purify CitS and reconstitute it into 
liposomes. In such a defined system, the ionic composi- 
tion at both sides of the membrane is exclusively deter- 
mined by the experimental design and not disturbed by 
other activities such as those of the sodium/proton an- 
tiporters present in E. coli membranes and K pneumo- 
niae Triton X-100 extracts. In order to purify CitS, we 
constructed fusions with the biotinylation domain of the 
oxaloacetate decarboxylase from K. pneumoniae or with 
an N-terminal tag of six histidine residues and purified 
these fusion proteins by affinity chromatography. 
*Corresponding author. Fax: (41) (1) 262 0647. 
Abbreviations: CitS, sodium-dependent citrate carder; CitSct, CitS with 
a C-terminally attached biotinylation domain derived from the ~t-sub- 
unit of oxaloacetate d carboxylase; CitS~, CitS with an N-terminally 
attached polyhistidine-tail; FCCP, carbonyl cyanide p-trittuoro- 
methoxyphenylhydrazone; IPTG, isopropyl-fl-o-thiogalactopyra- 
noside; oadGAB, genes encoding the Z-, ~t-, and fl-subunit of oxaloaee- 
tate decarboxylase from Klebsiella pneumoniae, r spectively. 
2. Experimental 
2.1. Bacterial strains and plasmids 
For plasmids pQE-8 (Qiagen Inc.) and pCitSn~ the Escherichia cob 
K12 strain M15[pREP4] (Qiagen) was used as host. All other plasmids 
were propagated in E. coli DH5ct (Bethesda Research Labora- 
tories). 
2.2. Media and antibiotics 
Luria broth (LB) and LB-agar were used for routine bacterial growth 
[3]. AmpiciUine was used at 100/zg/ml (Amp 1°°) and kanamycin at 25 
/~g/ml (Kin25). Simmons' citrate agar [4], supplemented with 4/zg/ml 
thiamine and Amp 1°° was used to select for citrate utilizing clones. 
2.3. Recombinant DNA work, DNA sequence analysis and PCR 
For routine work with recombinant DNA, established protocols 
were used [3]. Sequence analysis was performed according to the dide- 
oxynucleotide chain termination method [5] using a Taq DyeDeoxy 
terminator cycle sequencing kit and the model 370A DNA sequencer 
from Applied Biosystems. The following mixture (100/zl) was used for 
PCR: 20 mM Tris-HC1 pH 8.8, 10 mM KC1, 10 mM (NH4)2SO4, 2mM 
MgSO4, 0.1% Triton X-100, 500/zM of each deoxynucleoside tri- 
phosphate, 1 /zM forward primer, 1 /zM reverse primer and 1 /zg 
pGW234 (carrying the K pneumoniae g nes for citS and oadGAB) [6] 
as template. Two units of Vent DNA polymerase were added after an 
initial denaturation step at 94°C for 10 min. Thirty cycles were carried 
out for 90 s at 940C, 60 s at 50°C and 60 s at 70°C. PCR fragment A: 
the forward primer (5' GTC AGC GAC GGC GGT GAC GTC 3') is 
identical to bases 1502-1522 of the KPOXD (K. pneumoniae oxaloace- 
rate decarboxylase) sequence (GenBank/EMBL Data Bank, accession 
number J03885). The reverse primer (5' GTC GAC TCT AGA TTA 
CGC CAG GGT CAT CAG GG 3') is complementary to the bases 
1800-1819 of the same sequence entry. The primer extends at the 5' end 
by additional 12 bp comprising a XbaI restriction-site. PCR fragment 
B: the forward primer (5' CGG CGA TCG GTG GCT GGC TGA 3') 
is identical to bases 1450-1471 of the KPCITS (K. pneumoniae Na +- 
dependent citrate carrier) sequence (GenBank/EMBL Data Bank, ac- 
cession umber M83146). The reverse primer (5' CTC GAT GGA TCC 
AAT CAT CAT GCC GAA CAC GA 3') is complementary to bases 
1639 to 1658 of the same sequence ntry. It has a 12 bp extension at 
the 5' end containing a BamHI restriction site. PCR fragment C: the 
forward primer (5' GCT CGG TAC CCG GCC ~ GAT CCA TCG 
AGG GTA GGA TGA CTA ACA TGA GTC AG 3') is identical to 
bases 321-338 of the KPCITS sequence mentioned above and contains 
at the 5' end 35 bp matching the sequence of the multiple cloning site 
and the factor Xa recognition site encoding region of pMal-c 
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(New England Biolabs). The reverse primer (5' CAC CGG AGC GCC 
ACC G 3') is complementary to bases 557-572 of the KPCITS 
sequence. 
2.4. Construction of the CitS~t fusion and the 6xHis-tagged CitS-fusion 
PCR fragment B was restricted with StuIIBamHI and ligated into 
StulIBamHI restricted pKP-1 (a pGW234 derivate carrying only citS) 
to obtain pKP-1Astop. PCR fragment A was restricted with PvulI and 
XbaI and cloned into a StuIIXbaI restricted pMAL-c vector to obtain 
pMA-9, pMA-9 was restricted with BamHllXbaI and the resulting 319 
bp fragment (including a factor Xa recognition site) was ligated into 
BamHIIXbaI restricted pKP-1Astop to obtain pFXa (see Fig. 1). PCR 
fragment C was restricted with KpnlISphI and ligated into a KpnlISphI 
restricted pFXa to obtain pFXa-2 (Fig. 1). pFXa-2 was restricted with 
BamHI and the resulting 1355 bp fragment was isolated and ligated into 
a BamHI restricted, ephosphorylated pQE-8 vector to obtain pCitSH~. 
The DNA sequence of the fusion sites and the PCR derived sequences 
were controlled by sequencing. 
2.5. N-terminal sequencing and protein determination 
For N-terminal sequencing, 18 #g of purified CitSct were blotted onto 
a polyvinylidene difluoride-(PVDF-)membrane and treated as de- 
scribed [7]. N-terminal sequence analysis was performed using a protein 
sequencer with on-line PTH-(phenylthiohydantoin) amino acid detec- 
tion by HPLC. Protein was determined according to [8] using bovine 
serum albumin dissolved in the same buffer as the samples as standard. 
2.6. Determination of expression of the fusion protein and growth of 
E. coli DH5otlpFXa nd E. coli M15 [pREP4]IpCitSH~ 
E. coli DH5ct/pFXa cells were grown on LB Amp ~°° to an OD~ of 
0.8 to 1.2. After addition of 50/zM IPTG, the culture was grown for 
another 2 h and then harvested. E coli DHS~t harbouring pGW234 or 
pMA-9 was grown overnight in LB Amp ~°° and then harvested. Cells 
from 1 ml culture with an ODt00 = 1 were resuspended in 100/~1 of 
SDS-sample buffer and boiled for 5 min. Proteins from a 10/zl sample 
were separated by SDS-PAGE (10% acrylamide) [9], blotted onto a 
nitrocellulose filter [10] and stained with avidin-peroxidase [11]. Four 
liters of LB Amp ~°° were inoculated with 2 ml overnight culture of 
E. coli DH5ct/pFXa grown in the same medium at 37"C and 180 rpm. 
After the culture reached an ODt00 of 0.7 to 0.8 , 50/~M IPTG was 
added. The cells were allowed to grow for another 2 h before harvest. 
Two liters of LB Amp 1°° Km 2s were inoculated with 1 ml overnight 
culture of E. coli MI5 [pREP4]/pCitSa~ grown in the same medium at 
37"C and 180 rpm. The cells were grown until they reached the station- 
ary phase (OD600 = 2.2) and then harvested. Induction of E. coli M15 
[pREP4]/pCitSah with IPTG (even with 50/zM) was lethal for the cells 
and therefore avoided. 
2.7. Preparation of membranes and purification of the fusion proteins 
All phosphate buffers used in this study were prepared from K2HI~4 
or Na2HPO4 by adjusting the pH with HCI. Bacterial membrane vesi- 
cles were prepared by suspending 1 g cells (wet weight) of E. coli 
DH5~pFXa or E. coli M15[pREP4]/pCitSaiB n4 m120 mM K+-phos - 
phate buffer pH 7.5 containing 0.5 M NaC1, 0.2 mM diisopropylfluoro- 
phosphate (DFP), 1 mM Mg-EDTA and a trace amount of deoxyribo- 
nuclease and passing the suspension twice through a French pressure 
chamber at 82.7 MPa (12,000 psi). The suspension was centrifuged at 
4"C for 10 min at 10,000xg and the supernatant was centrifuged at 
4°C for 45 rain at 180,000 x g. The membrane pellet was washed twice 
with 5 ml 20 mM potassium-phosphate buffer pH 7.5 and resuspended 
in 0.5 m120 mM potassium-phosphate buffer pH 7.5 containing 0.5 M 
NaC1. The membrane vesicles were thoroughly mixed with 3% Triton 
X-100 and allowed to stand for 15 min on ice with occasional shaking 
before the mixture was centrifuged for 45 min at 180,000xg. The 
supernatant (Triton X-100 extract) could be stored at 4"C for a week 
without significant loss of citrate transport activity. For the purification 
of CitS0t, a Triton X-100 extract of E. coli DHS0dpFXa (8 ml, 80 mg 
protein) was applied to a monomeric avidin-Sepharose column (15 ml 
bed volume, prepared as described [12]) preequilibrated with 6 bedvo- 
lumes buffer A1 (20 mM K+-phosphate pH 6.0, 0.5 M NaCI, 1 mM 
K+-citrate, 0.1% dodecylmaltoside, 0.2mM DFP) or buffer A2 (20 mM 
K+-phosphate pH 6.0, 20 mM NaCI, 20 mM K+-citrate, 0.1% Triton 
X-100, 0.25 mglmi E. coli phospholipids (Avanti Polar Lipids), 0.2 mM 
DFP). The colunm was washed with 7 bed volumes of buffer A1 (or 
A2) to remove all unbound proteins. The biotinylated fusion protein 
was eluted with buffer AI (or A2) containing 1 mM (+)-biotin. The 
flow rate was 0.5 ml/min and 2 ml fractions were collected. Fractions 
containing CitS~ were pooled and concentrated 6- to 7-fold in an 
Amicon uitrafiltration chamber using a Diaflo PM-10 membrane. This 
concentrated protein solution could be stored for 3 weeks at 4"C or for 
several months in liquid nitrogen without significant loss of activity. 
For the purification of CitSn~, a Triton extract of E. coli 
M15[pREP4]/pCitSais (0.7 ml, 3.8 mg protein) was applied to a Ni 2+- 
NTA-colunm (Qiagen) with 1 ml bedvolume preequilibrated with 
buffer B (20 mM K+-phosphate buffer, pH 7.8 containing 20 mM NaC1, 
1 mM K+-citrate, 0.1% dodecylmaltoside and 0.2 mM DFP). The col- 
umn was washed with 6 bedvolumes of buffer B and afterwards with 
6 bedvolumes of buffer B adjusted to pH 6.0. The His-tagged protein 
was eluted with buffer B, pH 6.0, containing 100 mM imidazole. The 
flow rate was determined by gravitation and 1 ml fractions were col- 
lected. The purified protein could be stored at 4"C for at least a week 
without significant loss of activity. 
2.8. Reconstitution fpurified fusion protein and citrate transport assay 
To form liposomes a suspension of 14 mg of phosphatidylcholine 
(Sigma, type II S) in 930/zl reconstitution-buffer (50 mM K+-phosphate 
pH 6.0) was vigorously agitated with a vortex mixer for 3 rain and 
afterwards onicated for 3 x 1 min using a water bath-type sonicator. 
The purified fusion protein (70/zl, 6/zg of protein) was added to the 
preformed liposomes and the mixture was allowed to stand for 15 rain 
on ice with occasional shaking. In order to remove the undesired salts 
(citrate, NaC1) added with the protein, the mixture (1 ml) was applied 
to a NAP-10 column (Pharmacia) preeqnilibrated in reconstitution 
buffer and the proteoliposomes were eluted in this buffer. The first three 
drops containing proteoliposomes (detected by turbidity) were dis- 
carded and the next 0.5 ml were collected, frozen in liquid nitrogen, 
thawed in a water/ice bath and sonicated for 2 x 4 s in a water bath-type 
sonicator. The proteoliposomes were collected by centrifugation at 
180,000xg for 50 min and resuspended in 14/zl of reconstitution 
buffer, usually resulting in a total volume of 80/zl. Proteoliposomes (10 
/zl) loaded with 50 mM K÷-phosphate pH 6.0 were diluted into 490/zl 
50 mM Na+-phosphate pH 6.0 containing 4.5/tM [1,5-14C]citrate (140- 
160 cpndpmol). 100/zl samples were taken at various times, diluted into 
900/zl ice-cold 0.1 M LiC1, and rapidly filtered through 0.22/~m GSTF 
filters (Millipore). The filters were washed once with 1 ml ice-cold 0.1 
M LiCi and placed into scintillation vials. After addition of 4 ml scin- 
tillation fluid (Ready-safe, Beckman), the entrapped [1,5-14C]citrate was 
determined with a liquid scintillation counter. Experimental values 
were corrected for zero-time controls by diluting proteoliposomes (2/zl) 
into 98/zl 50 mM Na+-phosphate pH 6.0 containing 4.5/zM [1,5- 
~4C]citrate that had already been diluted with 900/zl ice-cold 0.1 M LiCI, 
followed by rapid filtration and washing of the sample as described 
above. 
3. Resu l ts  and d iscuss ion 
3.1. Construction o f  the fusion proteins 
The const ruct ion  o f  fus ion prote ins  by genet ic meth-  
ods and their  pur i f icat ion by aff inity chromatography  is 
a power fu l  techn ique o f  prote in  iso lat ion that  can be 
appl ied i f  the gene for  the desired prote in  is avai lable.  As  
repor ted  recent ly for  the lactose permease (LacY)  [13] 
and the I IBC~l%subunit  o f  the glucose t ranspor ter  f rom 
E. coli [14], pur i f icat ion by this method  yields h ighly 
pur i f ied proteins.  The  gene for  the Na+-dependent  c i trate 
carr ier  f rom K. pneumoniae (citS) was subc loned f rom 
p lasmid pGW234 which conta ins  in add i t ion  three genes 
encod ing  the oxa loacetate  decarboxy lase (oadGAB) 
downst ream o f  citS [6]. In  the result ing plasmid,  pKP-1 ,  
the stop codon o f  citS was deleted by PCR-methodo logy .  
A DNA f ragment  encod ing  the b iot in  acceptor  domain  
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of the K pneumoniae oxaloacetate d carboxylase a-sub- 
unit (residues 500-595) was amplified by PCR with 
pGW234 as template and cloned in-frame behind the 
DNA region of pMal-c encoding the recognition site of 
the endoproteinase factor Xa. Unfortunately, all clones 
obtained had a deletion of one 'G' at the fusion junction. 
The resulting frame-shift led to a TGA-stop codon di- 
rectly behind the gene of the maltose binding protein (see 
also Fig. 1). We concluded therefore that the maltose 
binding protein a-fusion was toxic and created a highly 
selective pressure in favour of the frame-shift mutant. 
Consequently, induction of expression from the tac pro- 
moter of pMal-c by IPTG was avoided and the clones 
were screened by restriction analysis. Under these condi- 
tions pMA-9 was obtained. A DNA fragment compris- 
ing the factor Xa recognition site plus the biotin acceptor 
domain was then fused in-frame behind the last codon 
of citS yielding pFXa. The correct sequence of the fusion 
sites and of DNA fragments derived from PCR products 
was verified by sequencing. In pFXa, the gene encoding 
the CitS-a peptide fusion protein is expressed from the 
lac promoter present on the vector pBluescript KS+ 
(data not shown), pFXa-2 was obtained by cloning a 
KI~ MUl  
I I'*" I" ~ '=" '~ 
I e lB  (1-44~ II=O ~od~ dl l l t ld  I 
j J  ~ ~  
mi le"  li lt Illdall 






I I m 
AI"r  QQA T00  ATO OAQ ~1"  AQQ o'rQ ACQ 
/ & __s  \ lilt mt~ll 
a18 ~ :  F.~m~Xm ~mmmt 
~qemm~mR d~Lmm 
I I r 
~ j  oas (~-,~ IO=dA (==0-a~ I pFXa-2 
lao'r P,~o ixla i~ l  iii ~ "rl=o A'~ (IMI ella1" ~U~I A'rli 
I e~ ~-4~ I i~ i tS~ 
Fig. 1. Schematic representation of plasmids encoding CitS (pKP-1, 
pKP-l~op), CitS~ (pFXa, pFXa-2), CitSn~(pCitSr~) and the MalE- 
~(500-595) fusion (pMA-9). Only the inserts and the vector parts used 
in the construction are shown. The deleted base ('G') in pMA-9 is 
shown in bolder letter-type (for details ee tex0. 
PCR-fragment encoding residues 1-25 of CitS and com- 
prising 35 base-pairs of the pMal-c polylinker egion at 
the 5' end, into pFXa. By inserting the polylinker egion 
of pMal-c upstream of citS-oad A (500-595), citS could 
easily be cloned into pQE-8, the source of the His-tag, 
yielding pCitSn~ (Fig. 1). 
3.2. Expression of biotin-containing fusion proteins 
The expression of biotinylated fusion proteins was ver- 
ified by Western blotting of cell extracts and staining 
with avidin-peroxidase (data not shown). The biotin pro- 
tein expressed by pMA-9 showed an apparent Mr of 
52,000 on SDS-PAGE as expected for maltose binding 
protein (Mr 42,000) fused to the biotin acceptor domain 
(Mr ---10,000). The biotin protein expressed by E. coli 
DH5a[pFXa] exhibited an apparent Mr of 50,000 which 
is smaller than expected (theoretical value =57,500) 
probably due to abnormal binding of SDS to the mem- 
brane protein. Plasmid pFXa led to modest growth inhi- 
bition of E. coli DH5a in LB Amp ~°° liquid medium 
because the ceils reached the stationary growth phase 
already at an OD~ of 1-2 whereas the vector control 
grew to an OD~ of 3-4. pFXa conferred the Cit*-pheno - 
type to E. coli under aerobic onditions proving that the 
CitSa fusion protein is a functional citrate carrier in vivo. 
This was confirmed by citrate transport experiments 
with proteoliposomes that were reconstituted with Tri- 
ton X-100 extract from membranes of DH5a[pFXa] 
(data not shown). 
3.3. Purification of the fusion proteins 
Membranes prepared from 12 g cells (wet weight) of 
E. coli DH5a[pFXa] were extracted with 3% Triton X- 
100 and the Triton extract (8 ml, 80 mg protein) was 
applied to a monomeric avidin-Sepharose column equil- 
ibrated with a buffer containing 0.1% dodecylmaltoside. 
After washing off all unbound proteins, the biotin-con- 
taining fusion protein (about 0.5 mg) was specifically 
eluted with column buffer containing 1 mM (+)-biotin. 
Alternatively, column buffers containing 0.1% Triton X- 
100 could be used, but in this case phospholipids from 
E. coli or K. pneumoniae (0.25 mg/ml) had to be present 
in the buffer to retain transport activity. The presence of 
citrate in the column buffers was essential for the stabil- 
ity of the carrier. Citrate carrier with an N-terminal his- 
tidine-tag was extracted from membranes of E. coli 
M15[pREP4]/pCitSn~ with 3% Triton X-100 and 0.7 ml 
Triton extract containing 3.8 mg protein were applied to 
a Ni2*-NTA-column equilibrated with buffer containing 
0.1% dodecylmaltoside. The column was successively 
washed with column buffer of pH 7.8 and 6.0 to remove 
unbound proteins. CitS~ was specifically eluted with 
column buffer pH 6.0 containing 100 mM imidazole. The 
yield was 72 gg of pure protein indicating that at least 
2% of the protein present in the Triton-extract was 
CitSHis. 
350 3.4. SDS-PAGE, Western blot analysis, and N-terminal 
sequencing 
The purified fusion proteins CitS¢ and CitSm, were 
analysed by SDS-PAGE. The results shown in Fig. 2 
indicate that both fusion proteins were highly purified by 
the procedure applied. Interestingly, purified CitS0t con- 
sisted of two about equally strong stained proteins with 
apparent Mr's of 50,000 and 33,000. The N-terminal 14 
amino acids of both polypeptides were identical and 
started with the threonine next to the methionine n- 
coded by the start codon of citS [2]. The proteinchemi- 
cally determined sequence matched the DNA-derived se- 
quence with the exception of an alanine at position 6 that 
had been predicted to be a proline. Resequencing of the 
5' part of citS in our laboratory revealed that the first 
base of the 6th codon is a 'G' rather than a 'C'. The 
correct codon is therefore 'GCT' which codes for alanine 
in accord with our protein sequence analysis. The identi- 
cal N-termini of the two proteins indicated that the 
polypeptide with an apparent Mr of 33,000 derived from 
that with an apparent Mr of 50,000 by C-terminal 
cleavage. However, besides these two polypeptides no 
other bands were visible, indicating that no proteolytic 
cleavage occurred uring the purification. These obser- 
vations were confirmed by Western-blot analysis how- 
ing that only the polypeptide with an apparent Mr of 
50,000 was biotinylated (Fig. 2, lane c). The co-purifi- 
cation of a biotinylated and a non-biotinylated polypep- 
tide by monomeric avidin-Sepharose chromatography 
indicated that CitS is an oligomeric protein. Moreover, 
since the ratio of the two forms after purification was 
about 1:1, whereas the non-biotinylated form was pres- 
ent in excessive amounts in the Triton X-100 extract 
(data not shown), native CitS is most probably a dimer. 
A similar approach was recently used to identify the 
dimeric structure of the IIBC tic protein [14]: if a mixture 
of wild-type IIBC ~lc and His-tagged IIBC c1¢ was loaded 
onto a Ni2÷-NTA-resin affinity column, both proteins 
were retained and eluted together, whereas wild-type 
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Fig. 2. SDS-PAGE and Western blot analysis of the purified fusion 
proteins. Lane A : CitS= purified by avidin-Sepharose affimty chroma- 
tography (6 pg protein); lane B: CitSni, purified by a Ni2*-NTA-aflinity 
column (0.5/lg of protein); the gels were stained with silver [15]; lane 
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Fig. 3. Citrate uptake into proteoliposomes containing purified CitS= 
(e) or CitSw (m). The proteoliposomes were prepared in the presence 
of 50 mM K+-phosphate buffer ofpH 6.0. The uptake of[1,5-14C]citrate 
was initiated by diluting 10 pl proteoliposomes into 490 pl 50 mM 
Na*-phosphate buffer of the same pH containing 4.5 pM [1,5J4C]cit- 
rate (ApNa+). In the controls the proteoliposomes containing either 
CitS~t or CitSH~ were diluted into K+-phosphate buffer, pH 6.0 contain- 
ing 4.5 #M [l,5J4C]citrate (&). The control experiments led to similar 
results for CitSet and CitSn~, therefore only one set of data is shown. 
Each time point represents he mean value of three assays. 
IIBC ~c alone did not bind to the column. In Fig. 2 (lane 
b), the N-terminally His-tagged CitS purified by the 
Ni2*-NTA-affinity column was applied. Obviously, only 
one polypeptide is apparent in this material which exhib- 
its an apparent Mr almost identical to the non-biotinyl- 
ated form of the CitS~t fusion protein. This result indi- 
cated that the polypeptide with an apparent Mr of 33,000 
detected in purified CitS0c represents most probably CitS 
without the attached a-peptide. Attempts to cleave off 
the ~-peptide in purified samples of CitS~ with the en- 
doproteinase factor Xa failed (data not shown). The 
question how the shortened CitS0~ derivative was formed 
cannot be answered definitively. Since a biotinylated 
degradation product of Mr -- 10,000 could be detected 
neither in the cell extract nor in the Triton extract nor 
in the avidin-Sepharose column effluent, it appears un- 
likely that the 33K protein results from proteolytic cleav- 
age. A more plausible xplanation for the appearance of
the 33K protein is by a mutation at the fusion junction 
leading to the generation of a stop codon. Exactly such 
an event had occurred during the construction of the 
maltose binding protein-0~ peptide fusion in pMA-9, indi- 
cating that there is a selective pressure in favour of it. 
Additional support for a mutation comes from the obser- 
KM. Pos et al./FEBS Letters 347 (1994) 37-41 41 
vation that the formation of biotinylated CitS0~ was con- 
siderably diminished after several transfers of E. coli 
DH50dpFXa into fresh medium. Such a behaviour is to 
be expected if cells carrying the mutated plasmid grow 
faster than cells with the original plasmid. 
3.5. Transport of citrate into proteoliposomes containing 
purified CitS fusion proteins 
Purified CitSa or CitSms was reconstituted into prote- 
oliposomes by the freeze/thaw/sonication procedure as 
outlined in section 2. When proteoliposomes were pre- 
pared in K+-phosphate buffer pH 6.0 and diluted into 
Na+-phosphate buffer of the same pH, citrate was rap- 
idly accumulated in response to the imposed ApNa + (Fig. 
3). Without imposition o fa  ApNa +, by diluting the prote- 
oliposomes into K+-phosphate buffer pH 6.0, citrate 
accumulation was poor and ceased after the first 30 sec- 
onds. Accumulation of citrate in liposomes without in- 
corporated CitS0c or CitSrlis was 20-fold less than in the 
proteoliposomes containing CitS~ or CitSri~ (data not 
shown). With the data obtained an 8-fold increase of 
specific activity in comparison with reconstituted Triton 
X-100 extracts of E. coli DH5a[pFXa] or E. coli 
M15[pREP4]/pCitSms was estimated. The purified prep- 
arations of CitSn~ and CitS~ exhibited the same specific 
citrate transport activity (--250 nmol 'min- l 'mg pro- 
tein-l), indicating that both proteins of the CitS~/CitS 
heterodimer are catalytically active. 
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